Concentric Capital Strategies LP Takes $11.12 Million Position in The Cooper Companies, Inc. $COO

Concentric Capital Strategies LP acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the fourth quarter, according to its most recent disclosure with the SEC. The fund acquired 135,663 shares of the medical device company’s stock, valued at approximately $11,119,000.

A number of other large investors have also recently made changes to their positions in the stock. New York Life Investment Management LLC lifted its position in shares of Cooper Companies by 0.6% during the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after buying an additional 158 shares in the last quarter. Root Financial Partners LLC lifted its position in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares in the last quarter. Allworth Financial LP lifted its position in shares of Cooper Companies by 14.1% during the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after buying an additional 167 shares in the last quarter. Mesirow Financial Investment Management Inc. lifted its position in shares of Cooper Companies by 1.3% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after buying an additional 175 shares in the last quarter. Finally, Blue Trust Inc. lifted its position in shares of Cooper Companies by 13.9% during the 4th quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after buying an additional 185 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 3.4%

NASDAQ COO opened at $65.05 on Thursday. The stock’s 50 day moving average is $64.58 and its 200 day moving average is $74.10. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The stock has a market cap of $12.69 billion, a PE ratio of 55.13, a P/E/G ratio of 1.76 and a beta of 0.87.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the company posted $0.96 EPS. The company’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently commented on COO shares. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Mizuho set a $85.00 price target on Cooper Companies and gave the stock an “outperform” rating in a report on Thursday, June 4th. Stifel Nicolaus lowered their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a report on Friday, June 5th. Barclays boosted their price target on Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, March 6th. Finally, JPMorgan Chase & Co. lowered their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, Cooper Companies presently has a consensus rating of “Hold” and an average target price of $81.31.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.